Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Ardelyx Inc (NQ: ARDX )

6.980 USD +0.080 (+1.16%)
Streaming Delayed Price Updated: 11:08 AM EST, Jan 28, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All news about Ardelyx Inc

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Ardelyx Announces Submission of New Drug Application to the U.S. FDA for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis
Application is Supported by Three Positive Phase 3 Clinical Trials for Tenapanor for Hyperphosphatemia, a Condition which affects Approximately 85% of CKD Patients on Dialysis 
From PR Newswire
Ardelyx Announces Positive Second Data Analysis from Ongoing NORMALIZE Phase 4 Study Evaluating Tenapanor in CKD Patients on Dialysis
Foundational use of tenapanor as monotherapy or with sevelamer enabled up to 47.4% of patients to achieve normal serum phosphorus levels (<4.6 mg/dL), a 58% improvement over current standard of care 
From PR Newswire
Ardelyx (ARDX) Shares Cross Below 200 DMA
In trading on Thursday, shares of Ardelyx Inc (ARDX) crossed below their 200 day moving average of $6.38, changing hands as low as $6.25 per share. Ardelyx Inc shares are currently trading down about... 
Tags Stocks
From Market News Video
Ardelyx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Ardelyx, Inc. (Nasdaq: ARDX), a specialized biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with kidney and cardiovascular diseases,... 
From PR Newswire
The Daily Biotech Pulse: Soleno Flunks Late-Stage Study, Sanofi Strikes Breast Cancer Partnership, NanoViricides Shortlists Coronavirus Treatment Candidates
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ENZ SRPT GBT
From Benzinga
Ardelyx Appoints Veteran Biopharma Executive, Justin Renz, as Chief Financial Officer
Ardelyx, Inc. (Nasdaq: ARDX), a specialized biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with kidney and cardiovascular diseases,... 
From PR Newswire
Ardelyx to Present at the Jefferies 2020 Virtual Healthcare Conference
Ardelyx, Inc. (Nasdaq: ARDX), a specialized biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with kidney and cardiovascular diseases,... 
From PR Newswire
Ardelyx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Ardelyx, Inc. (Nasdaq: ARDX), a specialized biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with kidney and cardiovascular diseases,... 
From PR Newswire
Ardelyx Strengthens Management Team with Appointment of Susan Rodriguez as Chief Commercial Officer
Ardelyx, Inc. (Nasdaq: ARDX), a specialized biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with kidney and cardiovascular diseases,... 
From PR Newswire
Ardelyx Reports First Quarter 2020 Financial Results and Recent Business Highlights
Company maintains strong balance sheet with $223.2 million in cash, cash equivalents and short-term investments 
From PR Newswire
How The Pieces Add Up: DWAS Headed For $55
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Knight Therapeutics Announces Approval of IBSRELA™ in Canada
From GlobeNewswire News Releases
Interesting ARDX Put And Call Options For May 15th
Investors in Ardelyx Inc (ARDX) saw new options become available this week, for the May 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ARDX options chain... 
Tags Stocks
From Market News Video
Ardelyx Appoints Onaiza Cadoret-Manier to its Board of Directors
Ardelyx, Inc. (NASDAQ: ARDX), a specialized biopharmaceutical company focused on developing innovative first-in-class medicines to improve treatment for people with cardiorenal diseases, today... 
From PR Newswire
ARDX Makes Notable Cross Below Critical Moving Average
In trading on Friday, shares of Ardelyx Inc (ARDX) crossed below their 200 day moving average of $5.11, changing hands as low as $5.05 per share. Ardelyx Inc shares are currently trading trading flat... 
Tags Stocks
From Market News Video
Ardelyx Q4 EPS $(0.27) Up From $(0.45) YoY, Sales $2.25M Up From $85K YoY
Ardelyx (NASDAQ:ARDX) reported quarterly losses of $(0.27) per share. This is a 40 percent increase over losses of $(0.45) per share ... 
Tags News ARDX Market News
From Benzinga
Ardelyx Reports Fourth Quarter and Full Year 2019 Financial Results and Recent Highlights
Ardelyx, Inc. (Nasdaq: ARDX), a specialized biopharmaceutical company focused on developing first-in-class medicines to improve treatment choices for people with cardiorenal diseases, today reported... 
From PR Newswire
Investors Grab ARDX Even Lower Than Its Secondary Stock Offering
Looking back to 93 days ago, Ardelyx Inc (ARDX) priced a 20,000,000 share secondary stock offering at $6.25 per share. Buyers in that offering made a considerable investment into the company, expecting... 
Tags Stocks
From Market News Video
First Week of October 16th Options Trading For Ardelyx (ARDX)
Investors in Ardelyx Inc (ARDX) saw new options begin trading this week, for the October 16th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the... 
Tags Stocks
From Market News Video
Ardelyx to Present at the Cowen and Company 40th Annual Health Care Conference
Ardelyx, Inc. (NASDAQ: ARDX) today announced that Mike Raab, president and chief executive officer of Ardelyx, will present at the Cowen and Company 40th Annual Health Care Conference at 8:00 a.m. ET... 
From PR Newswire
Stocks That Hit 52-Week Highs On Thursday
Before 10 a.m. ET on Thursday, 288 companies hit new 52-week highs. Highlights: The largest company by market cap to hit a new ... 
Tags ODFL Integrated Telecommunication Services SNN
From Benzinga
Ardelyx to Present at the 9th Annual SVB Leerink Global Healthcare Conference
Ardelyx, Inc. (NASDAQ: ARDX) today announced that Mike Raab, president and chief executive officer of Ardelyx, will present at the 9th Annual SVB Leerink Global Healthcare Conference at 3:30 p.m. ET on... 
From PR Newswire
80 Biggest Movers From Yesterday
Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares climbed 168.4% to close at $9.20 on Tuesday after the company ... 
Tags Market News I BWEN
From Benzinga
35 Healthcare Stocks Moving In Tuesday's Pre-Market Session
Gainers Stealth BioTherapeutics, Inc.(NASDAQ: MITO) stock increased by 38.4% to $3.10 during Tuesday's pre-market ... 
Tags Trading Ideas BBI MBIO
From Benzinga
Analysts See 18% Gains Ahead For The Holdings of BIB
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
Benzinga's Top Upgrades, Downgrades For February 12, 2020
Upgrades Northland changed the rating forCasa Systems Inc(NASDAQ: CASA) from Market Perform to Outperform. For the ... 
Tags MYFW MU Analyst Ratings
From Benzinga
Benzinga's Top Upgrades, Downgrades For February 10, 2020
Upgrades Chardan Capital upgraded the stock forAdverum Biotechnologies Inc(NASDAQ: ADVM) from Neutral to Buy. Adverum ... 
Tags ORCC ZION LYFT
From Benzinga
Double Your Money with This Biotech
With its first FDA approval in hand, a second, more lucrative indication looms on the horizon. 
Tags IRWD UNKNOWN Market News
From Motley Fool
How The Parts Add Up: PTH Targets $106
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
First Week of February 2020 Options Trading For Ardelyx (ARDX)
Investors in Ardelyx Inc (ARDX) saw new options become available this week, for the February 2020 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ARDX options... 
Tags Stocks
From Market News Video
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.